Prospera Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$573K Buy
+8,872
New +$486K 0.01% 979
2022
Q2
Sell
-176
Closed -$6K 2421
2022
Q1
$6K Buy
+176
New +$6.1K ﹤0.01% 2229
2020
Q4
Sell
-176
Closed -$7K 1392
2020
Q3
$7K Buy
+176
New +$7.26K ﹤0.01% 1216
2017
Q1
Sell
-18,275
Closed -$443K 414
2016
Q4
$443K Buy
+18,275
New +$438K 0.09% 206

Other funds holding SBIO

Prospera Financial Services's SBIO Position: Q2 2026 in Review

Prospera Financial Services opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026: 8,872 shares worth $573K. The stake represents 0.01% of the portfolio and ranks #979 among its holdings. This is a return to the name: Prospera Financial Services previously reported a position in SBIO as recently as Q1 2022.

Prospera Financial Services first reported a position in SBIO in Q4 2016 and has held it in 4 quarters since. 9 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Prospera Financial Services held 8,872 shares of ALPS Medical Breakthroughs ETF worth $573K as of Q2 2026.
  • ALPS Medical Breakthroughs ETF was a new Prospera Financial Services position in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #979 holding.
  • Prospera Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2016 and has held it in 4 quarters since.
  • 9 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.